Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Dorzolamide and timolol
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops
1106000ABAAAAAA
|
Dorzolamide and timolol | Dorzolamide and timolol | Eye | 110,601 |
|
Dorzolamide 20mg/Timolol 5mg/ml eye dps 0.2ml preserv free
1106000ABAAABAB
|
Dorzolamide and timolol | Dorzolamide and timolol | Eye | 43,688 |
|
Cosopt 20mg/ml / 5mg/ml eye dps 0.2ml ud preservative free
1106000ABBBABAB
|
Cosopt | Dorzolamide and timolol | Eye | 30,093 |
|
Dorzolamide 20mg/ml / Timolol 5mg/ml eye dps preserv free
1106000ABAAACAC
|
Dorzolamide and timolol | Dorzolamide and timolol | Eye | 26,606 |
|
Cosopt 20mg/ml / 5mg/ml eye drops
1106000ABBBAAAA
|
Cosopt | Dorzolamide and timolol | Eye | 16,694 |
|
Cosopt iMulti 20mg/ml / 5mg/ml eye drops preservative free
1106000ABBBACAC
|
Cosopt | Dorzolamide and timolol | Eye | 4,232 |
|
Eylamdo 20mg/ml / 5mg/ml eye drops
1106000ABBDAAAC
|
Eylamdo | Dorzolamide and timolol | Eye | 2,390 |
|
Vizidor Duo 20mg/ml / 5mg/ml eye drops
1106000ABBEAAAC
|
Vizidor Duo | Dorzolamide and timolol | Eye | 841 |
|
Dorzolamide 20mg/Timolol 5mg/ml eye dps 0.166ml preserv free
1106000ABAAADAD
|
Dorzolamide and timolol | Dorzolamide and timolol | Eye | 341 |
|
Codimaz 20mg/ml / 5mg/ml eye drops
1106000ABBFAAAC
|
Codimaz | Dorzolamide and timolol | Eye | 318 |
|
Glaucopt 20mg/ml / 5mg/ml eye dps 0.166ml ud preserv free
1106000ABBGAAAD
|
Glaucopt | Dorzolamide and timolol | Eye | 105 |
|
Tidomat 20mg/ml / 5mg/ml eye drops
1106000ABBCAAAA
|
Tidomat | Dorzolamide and timolol | Eye | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.